𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bayer and Rhodia acquire catalysts licence

Publisher
Elsevier Science
Year
2002
Weight
31 KB
Volume
2002
Category
Article
ISSN
1351-4180

No coin nor oath required. For personal study only.

✦ Synopsis

Chiral intermediates plants for BASF

BASF is operating three plants for making chiral intermediates to meet rising demand from life science customers. The new plants reflect the advancement in the firm's proprietary technology and provide solutions to the limitations of previous plants in use. The active intermediates are used in making pharmaceutical and agrochemical compounds. The firm's 2500 tonne/y optically active amine plant in Gesmar, LA, produces the key ingredient for the firm's Outlook herbicide. The plant is based on a proprietary biocatalytic enzymatic process. The same technology is used in the multi-product cGMP plant in Ludwigshafen, Germany, which has a production capacity of over 1000 tonne/y. The third plant in Ludwigshafen uses a biocatalytic process to produce R-mandelic acid.

πŸ“œ SIMILAR VOLUMES

Elevance Renewable Sciences and Evonik a
Elevance Renewable Sciences and Evonik announce metathesis catalysts licence agreement
πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier Science βš– 59 KB

company. Both partners have also concluded long-term agreements concerning contract manufacturing and precious metal recycling. Based on these agreements, Ravindra Heraeus will continue to produce precious metal catalysts for the Indian market and recycle used catalysts at its site in Udaipur on beh